HESI Global Application of Genomics to Mechanism-Based Risk Assessment

Committee Events

October 19, 2010:  Genomics Applications in Safety Studies Workshop
Use of MicroRNAs in Toxicological Applications."  Washington, DC (by invitation)


August 27-28, 2009:  Workshop
"Genomics in Cancer Risk Assessment."  Co-organized by the carcinoGENOMICS Program, ECVAM, HESI Application of Genomics to Mechanism-based Risk Assessment Technical Committee, Netherlands Genomics Initiative.  Click here for information on this event.

October 27-28, 2008:  Genomics Applications in Safety Studies Workshop
Click here for information on this event.

November 7 - 8, 2007:  HESI Genomics Committee Symposium
Click here for information on this event.

 October 10, 2007:  HESI Genomics Committee Presentation
“Toxicogenomics: An Overview of Ongoing Projects by the HESI Committee on Genomics in Risk Assessment.”  Presented at the 44th Congress of the European Societies of Toxicology.  Amsterdam, The Netherlands.  Presentation by Jon Lyon, GlaxoSmithKline.  Amsterdam, The Netherlands.

 July 17, 2007:  HESI Genomics Committee Presentation
“Advancing Toxicogenomics Applications In Risk Assessment Through HESI And Other Collaborative Research Programs.”   Presented at the International Congress of Toxicology 2007 Meeting, Montreal, Canada. Presentation by Peter G. Lord (Johnson & Johnson Pharmaceutical Research & Development LLC).

 March 27, 2007:  HESI Genomics Committee Poster Presentation
“Identification of Biologically Relevant Genes Using a Database of Rat Liver and Kidney Baseline Gene Expression.”  Presented at the 46th Annual Meeting of the Society of Toxicology, Charlotte, NC.  HESI Genomics Committee. Presentation by Jeff Chou (NIEHS), J. Liu (NIEHS), Susan Hester  and J. S. Lee (NHEERL, U.S. EPA), Karol Thompson (CDER, U.S. FDA), Mike Bass (Amgen),  Mike Boedigheimer (Amgen), Jennifer Fostel (NIEHS), Fenglong Liu (Dana-Farber Cancer Institute), Russ Wolfinger (SAS), Pierre Bushel (NIEHS),  and Chris Corton (U.S. EPA). 

 March 27, 2007:  HESI Genomics Committee Poster Presentation
“Sources of Variability in Baseline Gene Expression in Rat Liver and Kidney.”  Presented at the 46th Annual Meeting of the Society of Toxicology, Charlotte, NC.  HESI Genomics Committee.  Presentation by Karol Thompson (CDER, U.S. FDA), Mike Bass (Amgen),  Mike Boedigheimer (Amgen), Pierre Bushel (NIEHS), Jeff Chou (NIEHS), Chris Corton (U.S. EPA), Jennifer Fostel (NIEHS), Fenglong Liu (Dana-Farber Cancer Institute), and Russ Wolfinger (SAS).

 March 26, 2007:  HESI Genomics Committee Poster Presentation
“A HESI Study of Doxorubicin Induced Cardiotoxicity in Rats.”  Presented at the 46th Annual Meeting of the Society of Toxicology, Charlotte, NC.  HESI Genomics Committee. Presentation by Qihong Huang (Boehringer Ingelheim), Jon Lyon (GlaxoSmithKline), Hisham Hamadeh (Amgen), Eugene Herman (U.S. FDA), Michelle Embry (HESI), Syril D. Pettit (HESI), Bhaskar Gollapudi (Dow Chemical), Steven Lipshultz, Robert Roth (Michigan State University), Paul Ciaccio (AstraZeneca), Todd Auman (NIEHS), Yasmina Bauer (Actelion Pharmaceuticals), Mike Cunningham (NIEHS), John Davis (Pfizer), Gordon Gibson (University of Surrey, UK), Wafa Harrouk (U.S. FDA), Richard Haworth (GlaxoSmithKline), Michael Holsapple (HESI), Axel Klenk (Actelion Pharmaceuticals), John Leighton (U.S. FDA), George Orphanides (AstraZeneca), Rick Paules (NIEHS), Frank Staedtler (Novartis Pharma AG), Scott Thurmond (U.S. FDA),  and Jonathan Tugwood (AstraZeneca).